Challenges in orphan drug development and regulatory policy in China

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 16,596 followers.

Open Access Challenges in orphan drug developmentand regulatory policy in China https://t.co/a9GMadQIIn

RT @ojrarediseases: Challenges in orphan drug development and regulatory policy in China- a new review in #OJRD #RareDisease https://t.co…

Challenges in orphan drug development and regulatory policy in China- a new review in #OJRD #RareDisease https://t.co/V3CZybM5ON

#ngs #genomics Challenges in orphan drug development and regulatory policy in China https://t.co/9hDkoaALiB https://t.co/tWg3nxkyz1

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.